KALA BIO raises $10M in registered direct offering of common stock and pre-funded warrants

KALA BIO, Inc.

Sold 900K shares and pre-funded warrants for 9.1M shares at $1.00 per share (warrants at $0.9999).
Gross proceeds of $10M; net proceeds to be used to repay indebtedness and for general corporate purposes.
Offering closed on December 5, 2025; H.C. Wainwright & Co. acted as exclusive placement agent.
Placement agent fee of 8.0% of gross proceeds plus $50K legal and $15,950 clearing expenses.

item 1.01 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001829126-25-009747
form_type: 8-K
ticker: KALA
cik: 0001479419
company_name: KALA BIO, Inc.
filed_at: 2025-12-05T23:59:59+00:00
discovered_at: 2026-05-14T18:02:39.495726+00:00
generated_at: 2026-05-16T14:13:49.841449+00:00
sec_items: ["1.01", "8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001829126-25-009747
json_url: https://secwatch.observer/filing/0001829126-25-009747.json
markdown_url: https://secwatch.observer/filing/0001829126-25-009747.md
text_url: https://secwatch.observer/filing/0001829126-25-009747.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1479419/000182912625009747/0001829126-25-009747-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1479419/000182912625009747/kalabio_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001829126-25-009747

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.